Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

DOI

    Erkka Valovirta, Department of Lung Disease and Clinical Allergology, University of Turku, Turku, Finland; Terveystalo Allergy Clinic, Turku, Finland. Electronic address: erkka.valovirta@terveystalo.com., Thomas H Petersen, Department of Paediatrics, Lillebaelt Hospital, and Institute of Regional Health Research, University of Southern Denmark, Skovvangen, 6000, Kolding, Denmark., Teresa Piotrowska, NZOZ Promedica, Białystok, Poland., Mette K Laursen, Global Clinical Development, ALK, Hørsholm, Denmark.,
  • Jens S Andersen
  • Helle F Sørensen, Global Clinical Development, ALK, Hørsholm, Denmark., Rabih Klink, Office of Paediatrics and Allergology Pneumo Pédiatric, Laon, France., GAP investigators (Rubak S)
OriginalsprogEngelsk
TidsskriftThe Journal of allergy and clinical immunology
Vol/bind141
Tidsskriftsnummer2
ISSN0091-6749
DOI
StatusUdgivet - 2018

Se relationer på Aarhus Universitet Citationsformater

ID: 116307999